The myeloid/microglia marker CX3CR1 was expressed on the surface of most MGLCs (72 ± 11% BU, 82 ± 7% BU + PLX), naïve MG (96 ± 0.8%), and disease MG (90±1.4% Fig. 4e–f), with MGLCs showing lower expression than naïve MG (Fig. 4f). This evidence concerns the gene CX3CR1 and myasthenia gravis.